文献速递慢性肾脏病

肥胖治疗重磅药物:肾内科医生入门指南

Blockbuster Medications for Obesity: A Primer for Nephrologists.
PubMed 文献 · Am J Kidney Dis · 2023-07-25

本文综述肥胖与减重对慢性肾脏病(CKD)的影响,以及基于肠促胰素系统的新型药物治疗的生物学基础与临床证据,指出新型药物减重效果接近手术且反复显示心血管保护作用,并提供推荐处方实践作为实用工具。

要点

  • 肥胖增加CKD风险并加剧心血管疾病负担。
  • 有证据提示有意减重对肾脏和心血管结局有保护作用。
  • 新型肠促胰素类药物减重效果接近手术且具心血管保护作用。

核心结论

  • 肥胖增加CKD风险并加剧心血管疾病负担,有意减重可能对肾脏和心血管结局有保护作用,新型肠促胰素类药物减重效果接近手术且具心血管保护作用。

研究设计与样本

  • 本文为综述,回顾肥胖与减重对CKD的影响以及肠促胰素治疗的生物学基础与临床证据。

主要发现

  • 肥胖不仅增加CKD风险,还加剧现有心血管疾病负担。
  • 有意减重对不良肾脏和心血管结局有保护作用,但CKD中减重治疗的角色仍有争议。
  • 新型肠促胰素类药物减重效果接近手术干预,并反复显示心血管保护作用。

临床怎么用

  • 本文提供推荐处方实践作为实用工具,以促进肾内科医生和CKD患者参与肥胖相关疾病治疗。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The prevalence of obesity in the United States and across the world continues to climb, imparting increased risk of chronic disease. This impact is doubly felt in nephrology because obesity not only increases the risk of chronic kidney disease (CKD) but also exacerbates existing cardiovascular morbidity and mortality. The role of medical weight loss therapy in CKD has been debated, but increasing evidence suggests that intentional weight loss is protective against adverse kidney and cardiovascular outcomes. This may be particularly true with the advent of novel pharmacotherapies taking advantage of the incretin system, resulting in weight loss approaching that seen with surgical interventions. Moreover, these novel therapies have repeatedly demonstrated protective effects on the cardiovascular system. Here, we review the impact of obesity and weight loss on CKD, and the biological basis and clinical evidence for incretin therapy. This perspective provides recommended prescribing practices as a practical tool to engage nephrologists and patients with CKD in the treatment of obesity-related morbidity.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Zeitler EM, Dabb K, Nadeem D, et al. Blockbuster Medications for Obesity: A Primer for Nephrologists. Am J Kidney Dis. 2023. PMID: 37500048. doi:10.1053/j.ajkd.2023.04.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。